400
Participants
Start Date
December 12, 2019
Primary Completion Date
November 2, 2028
Study Completion Date
November 2, 2028
Sutimlimab
CAD patients in Sutimlimab cohort must be treated according to routine clinical practice
RECRUITING
Investigational Site Number : 3102, Vienna
RECRUITING
Investigational Site Number : 3202, Quimper
RECRUITING
Investigational Site Number : 3101, Salzburg
RECRUITING
Investigational Site Number : 3701, Barcelona
RECRUITING
Center for Blood Disorders Site Number : 1214, New York
RECRUITING
Northwell Health-Monter Cancer Center-North Shore University Hospital and Steven and Alexandra Cohen Children's Medical Center of New York (Schneider Children's Hospital)-North Shore Long Island Jewis Site Number : 1231, Lake Success
RECRUITING
SUNY Upstate Medical University Site Number : 1221, Syracuse
RECRUITING
University of Pittsburgh Medical Center-UPMC Hillman Cancer Center Site Number : 1210, Pittsburgh
RECRUITING
MedStar Georgetown University Hospital / Lombardi Comprehensive Cancer Center Site Number : 1208, Washington D.C.
RECRUITING
Investigational Site Number : 3219, Dijon
RECRUITING
Investigational Site Number : 3413, Brescia
RECRUITING
Investigational Site Number : 3415, Pavia
RECRUITING
Brody School of Medicine at East Carolina University Site Number : 1203, Greenville
RECRUITING
Investigational Site Number : 3712, Madrid
RECRUITING
Investigational Site Number : 3403, Novara
RECRUITING
Investigational Site Number : 3306, Hanover
RECRUITING
Piedmont Cancer Institute, P.C Site Number : 1226, Atlanta
RECRUITING
Investigational Site Number : 3218, Toulouse
RECRUITING
Investigational Site Number : 3203, Pessac
RECRUITING
Investigational Site Number : 3220, Rennes
RECRUITING
University of Alabama at Birmingham Site Number : 1230, Birmingham
RECRUITING
Investigational Site Number : 3204, Cesson-Sévigné
RECRUITING
UT Medical Center Cancer Institute Site Number : 1237, Knoxville
RECRUITING
Investigational Site Number : 3205, Saint-Priest-en-Jarez
RECRUITING
The Ohio State University Site Number : 1236, Columbus
RECRUITING
Cleveland Clinic Foundation Site Number : 1207, Cleveland
RECRUITING
Investigational Site Number : 3301, Essen
RECRUITING
Investigational Site Number : 3412, Ravenna
RECRUITING
Henry Ford Hospital Site Number : 1232, Detroit
RECRUITING
Investigational Site Number : 3214, Angers
RECRUITING
Siouxland Regional Cancer Center dba June E. Nylen Cancer Center Site Number : 1220, Sioux City
RECRUITING
Orchard Heathcare Research Inc. Site Number : 1202, Skokie
RECRUITING
Investigational Site Number : 3213, Pau
RECRUITING
Investigational Site Number : 3211, Chalon-sur-Saône
RECRUITING
Investigational Site Number : 3221, Epagny-Metz-Tessy
RECRUITING
Investigational Site Number : 3217, Paris
RECRUITING
Investigational Site Number : 3222, Amiens
RECRUITING
Investigational Site Number : 3302, Landshut
RECRUITING
Investigational Site Number : 3216, Poitiers
RECRUITING
Investigational Site Number : 3410, Campobasso
RECRUITING
Investigational Site Number : 3402, Reggio Calabria
RECRUITING
Investigational Site Number : 3411, Palermo
RECRUITING
Investigational Site Number : 3206, Corbeil-Essonnes
RECRUITING
SLO Oncology and Hematology Site Number : 1235, San Luis Obispo
RECRUITING
Mission Hope Medical Oncology Site Number : 1241, Santa Maria
RECRUITING
Investigational Site Number : 3201, Créteil
RECRUITING
Hematology Oncology Associates, PC Site Number : 1211, Medford
RECRUITING
University of Washingtion Seattle Cancer Care Alliance Site Number : 1238, Seattle
RECRUITING
Reliant Medical Group Site Number : 1205, Worcester
RECRUITING
Investigational Site Number : 3404, Roma
RECRUITING
Investigational Site Number : 3405, Terni
RECRUITING
Investigational Site Number : 2203, Fukushima
RECRUITING
Investigational Site Number : 2204, Himeji-shi
RECRUITING
Investigational Site Number : 3603, Truro
RECRUITING
Investigational Site Number : 3617, Carlisle
RECRUITING
Investigational Site Number : 3608, Gillingham
RECRUITING
Investigational Site Number : 3605, London
RECRUITING
Investigational Site Number : 3602, Salford
RECRUITING
Investigational Site Number : 3623, Airdrie
RECRUITING
Investigational Site Number : 3601, Newcastle upon Tyne
RECRUITING
Investigational Site Number : 3613, Middlesbrough
RECRUITING
Investigational Site Number : 3611, Oxford
RECRUITING
Investigational Site Number : 3606, Taunton
RECRUITING
Investigational Site Number : 3618, Birmingham
RECRUITING
Investigational Site Number : 3620, Harrow
RECRUITING
Investigational Site Number : 3612, Leeds
RECRUITING
Investigational Site Number : 3607, Liverpool
RECRUITING
Investigational Site Number : 3621, London
Recordati Rare Diseases
INDUSTRY